Xcout IntelSign inSubscribe

Azenta, Inc. competitors & alternatives

AZTABiotechBurlington, United States

The 12 closest competitors and alternatives to Azenta, Inc. among biotech companies — ranked by similarity to what Azenta, Inc. actually does, not by market-cap band.

$1.6BMarket cap
2,900Employees
12Competitors listed

Subscribe to see Azenta, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Azenta, Inc.

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

Azenta, Inc. at a glance

Azenta, Inc. is a biotech company headquartered in Burlington, United States. It is publicly listed (AZTA) with a market capitalisation of $1.6B. Xcout tracks 28 named people at Azenta, Inc., including John Marotta (President, Chief Executive Officer & Director). Xcout recorded 129 job postings from Azenta, Inc. in the last 90 days, naming tools such as Salesforce, Workday, Power BI.

Azenta, Inc. leadership

  • John MarottaPresident, Chief Executive Officer & Director
  • Martin D MadausInterim President, CEO & Director
  • Lawrence Y. LinExecutive Vice President & Chief Financial Officer
  • Olga PirogovaSenior Vice President & Chief HR Officer
  • Erik J. BelloVice President, Chief Accounting Officer & Principal Accounting Officer
  • Michael PauloVice President, Chief Information & Digital Officer

22 more named people on record for Azenta, Inc., with roles, board committees and tenure — see the full roster →

Hiring at Azenta, Inc.

Xcout recorded 129 job postings from Azenta, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Azenta, Inc.'s job postings

SalesforceWorkdayPower BITableauChatGPTOracle ERPMicrosoft CopilotNetSuiteSAP

The weekly hiring trend, the roles and locations behind it — see Azenta, Inc.'s hiring signals →

Top 12 Azenta, Inc. competitors

Ranked by semantic similarity — how close each company is to Azenta, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

RevvityRVTY · Life Sciences, DiagnosticsWaltham, United States
69% matchPublic

Life Sciences, Diagnostics

Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.

Market cap$12.3B
Employees11,000
JavaScriptReact
Revvity competitors & alternatives →
Illumina0J8Z · BiotechSan Diego, United States
66% matchPublic

Similar biotech company

Illumina, Inc. specializes in delivering advanced sequencing and array technologies designed for genetic and genomic examination. These offerings cater to a diverse array of markets, fostering the widespread use of genomic insights across both research laboratories and clinical environments. Key application areas include life sciences, cancer diagnostics, reproductive medicine, agricultural science, and various nascent fields. The company's portfolio encompasses specialized instrumentation and associated consumables vital for genetic analysis. Additionally, it offers comprehensive genotyping and sequencing services, extends instrument maintenance contracts, and engages in development and licensing partnerships, alongside providing cancer screening services. Illumina's client base is extensive, comprising genomic research facilities, universities, state-funded laboratories, and healthcare providers. It also serves pharmaceutical firms, biotechnology companies, commercial molecular diagnostics providers, and businesses focused on consumer genomics. Globally, Illumina distributes its products through direct sales channels in North America, Europe, Latin America, and the Asia-Pacific. Furthermore, it leverages third-party life-science distributors to reach markets across Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.

Market cap$28.1B
Employees8,600
Illumina competitors & alternatives →
10x Genomics, Inc.TXG · BiotechPleasanton, United States
66% matchPublic

Similar biotech company

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Market cap$7.1B
Employees1,306
10x Genomics, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Azenta, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Azenta, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →